Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Inequity in Physician Compensation Is Killing Private Practice.

Missouri medicine·2026
Same author

A New Paradigm to Put US Healthcare Back on Track.

Missouri medicine·2026
Same author

Massive Data Breech Predicted by Missouri Medicine Eventuates.

Missouri medicine·2026
Same author

Missouri Medicine Moments The 2025 Chronicle.

Missouri medicine·2025
Same author

You Have Sudden Onset Chest Pain? The Doctor Can See You in 5 Months. The Travesty of Physician Unavailability.

Missouri medicine·2025
Same author

Compounding Pharmacists: Key Educators on Timolol Nasal Spray for Acute Migraine.

International journal of pharmaceutical compounding·2025

Related Experiment Video

Updated: May 8, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Eye on statins: A comprehensive review.

Evan A Olson1, Dean P Hainsworth, Geetha Davis

  • 1Mason Eye Institute, University of Missouri, USA. olsonea@health.missouri.edu

Missouri Medicine
|September 6, 2013
PubMed
Summary
This summary is machine-generated.

Statins are generally safe for eye health, with no significant link to cataracts. Further research is needed on statins' effects on glaucoma and age-related macular degeneration (ARMD).

Related Experiment Videos

Last Updated: May 8, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Cardiology

Background:

  • Statins have been widely prescribed for 25 years.
  • Ophthalmologic safety data for statins is extensive.
  • Potential ocular side effects require ongoing evaluation.

Purpose of the Study:

  • To review the ophthalmologic safety profile of statins.
  • To assess the association between statin use and ocular conditions.
  • To identify areas for future research regarding statins and eye health.

Main Methods:

  • Review of existing literature and prospective studies.
  • Analysis of data concerning statins and cataract formation.
  • Evaluation of statin impact on age-related macular degeneration (ARMD) and glaucoma.

Main Results:

  • Statins demonstrate a strong safety record in ophthalmology.
  • Evidence linking statins to clinically significant cataract formation is weak.
  • No proven benefit of statins for ARMD; some patients may have increased risk for wet ARMD.
  • Statin use in glaucoma requires further investigation.
  • Statins may potentially unmask or worsen myasthenia gravis.

Conclusions:

  • Statins are safe for ophthalmic use, with minimal cataract risk.
  • Further prospective studies are necessary for glaucoma and ARMD.
  • Caution is advised regarding potential exacerbation of myasthenia gravis.